Design, synthesis, and biological evaluation of β-lactam antibiotic-based imidazolium- and pyridinium-type ionic liquids

Chemical Biology and Drug Design

Volumn 78, Issue 1, 2011, Pages 33-41

  Cole, Marsha R ^a   Li, Min ^a   El Zahab, Bilal ^a   Janes, Marlene E ^b   Hayes, Daniel ^a   Warner, Isiah M ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

Author keywords

lactam; Antibacterial; Cetylpyridinium; Imidazolium; Ionic liquid; Quaternary ammonium compounds; Sodium ampicillin

Indexed keywords

1 HEXADECYL 2,3 DIMETHYLIMIDAZOLIUM AMPICILLIN; 1 HEXADECYL 3 METHYLIMIDAZOLIUM AMPICILLIN; AMPICILLIN; AMPICILLIN DERIVATIVE; BETA LACTAM ANTIBIOTIC; CETYLPYRIDINIUM AMPICILLIN; IMIDAZOLE DERIVATIVE; IONIC LIQUID; PYRIDINIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI O157; KLEBSIELLA PNEUMONIAE; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; IMIDAZOLES; INHIBITORY CONCENTRATION 50; IONS; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; MICROBIAL SENSITIVITY TESTS; PYRIDINIUM COMPOUNDS; SOLUBILITY;

ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; STAPHYLOCOCCUS AUREUS;

EID: 80955177472     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2011.01114.x     Document Type: Article

References (52)

1. Maheshwari R. (2007) Combating antibiotic resistance in bacteria. Indian J Microbiol;47:181-183.
2. Crowley P.J., Martini L.G. (2004) Formulation design: new drugs from old. Drug Discov Today Ther Strateg;1:537-542.
3. Nelson R. (2003) Antibiotic development pipeline runs dry. Lancet;362:1726-1727.
4. Congress U.S. (1995) Impacts of Antibiotic Resistant Bacteria ed. Assessment, O.o.T. Washington, DC: U.S. Government Printing Office.
5. Cole E.C., Addison R.M., Rubino J.R., Leese K.E., Dulaney P.D., Newell M.S., Wilkins J., Gaber D.J., Wineinger T., Criger D.A. (2003) Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers. J Appl Microbiol;95:664-676.
6. Lancini G.C., Parenti F., Gallo G.G. (1995) Antibiotics: A Multidisciplinary Approach. New York: Plenum Press.
7. Hsueh P.-R., Chenc W.-H., Teng L.-J., Luha K.-T. (2005) Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents. Int J Antimicrob Agents;26:43-49.
8. Del Sesto R.E., McCleskey T.M., Burrell A.K., Baker G.A., Thompson J.D., Scott B.L., Wilkes J.S., Williams P. (2008) Structure and magnetic behavior of transition metal based ionic liquids. Chem Commun;4:447-449.
9. Tesfai A., El-Zahab B., Bwambok D., Baker G., Fakayode S., Lowry M., Warner I. (2008) Controllable formation of ionic liquid micro- and nanoparticles via melt-emulsion-quench approach. Nano Lett;8:897-901.
10. Welton T. (1999) Room-temperature ionic liquids. Solvents for synthesis and catalysis. Chem Rev;99:2071-2083.
11. Wasserscheid P., Welton T. (editors) (2008) Ionic Liquids in Synthesis. London: Wiley-VCH.
12. Bwambok D.K., Marwani H.M., Fernand V.E., Fakayode S.O., Lowry M., Negulescu I., Strongin R.M., Warner I.M. (2008) Synthesis and characterization of novel chiral ionic liquids and investigation of their enantiomeric recognition properties. Chirality;20:151-158.
13. Li M., de Rooy S., Bwambok D.K., El-Zahab B., DiTusa J.F., Warner I.M. (2009) Magnetic chiral ionic liquids derived from amino acids. Chem Commun;7:6922-6924.
14. Binnemans K. (2006) Ionic liquids. Chem Rev;105:4128-4204.
15. Hough-Troutman W.L., Smiglak M., Rodriguez H., Swatloski R.P., Spear S.K., Daly D.T., Pernak J., Grisel J.E., Carliss R.D., Soutullo M.D., Davis J.H., Rogers R.D. (2007) The third evolution of ionic liquids: active pharmaceutical ingredients. New J Chem;31:1429-1436.
16. Docherty K.M., Kulpa C.F. (2005) Toxicity and antimicrobial activity of imidazolium and pyridinium ionic liquids. Green Chem;7:185-189.
17. Demberelnyamba D., Seung P., Huen L., Chang K., Ick-Dong Y. (2004) Synthesis and antimicrobial properties of imidazolium and pyrrolidinonium salts. Bioorg Med Chem;12:853-857.
18. Hough-Troutman W.L., Smiglak M., Griffin S., Reichert W.M., Mirska I., Jodynis-Leibert J., Adamska T., Nawrot J., Stasiewicz M., Rogers R.D., Pernak J. (2009) Ionic liquids with dual biological function: sweet and anti-microbial, hydrophobic quaternary ammonium-based salts. New J Chem;33:26-33.
19. Carter E.B., Culver S.L., Fox P.A., Goode R.D., Ntai I., Tickell M.D., Traylor R.K., Hoffman N.W., Davis J.H. (2004) Sweet success: ionic liquids derived from non-nutritive sweetners. Chem Commun;6:630-631.
20. Kumar R.A., Papaiconomou N., Lee M.-J., Salminen J., Clark D.S., Prausnitz J.M. (2009) In vitro cytotoxicities of ionic liquids: effect of cation rings, functional groups, and anions. Environ Toxicol;24:388-395.
21. Garcia-Lorenzo A., Tojo E., Tojo J., Teijeira M., Rodriguez-Berrocal F., Gonzalez M., Martinez-Zorzana V. (2008) Cytotoxicity of selected imidazolium-derived ionic liquids in he human caco-2 cell line. Sub structural toxicological interpretation through a qsar study. Green Chem;10:508-516.
22. Stolte S., Arning J., Bottin-Weber U., Matzke M., Stock F., Thiele K., Uerdingen M., Welz-Biermann U., Jastorff B., Ranke J. (2006) Anion effects on the cytotoxicity of ionic liquids. Green Chem;8:621-629.
23. Qiu L., Bae Y. (2006) Polymer architecture and drug delivery. Pharm Res;23:1-30.
24. Torchilin V. (2007) Micellar nanocarriers: pharmaceutical perspectives. Pharm Res;24:1-16.
25. Peppas N.A. (1997) Hydrogels and drug delivery. Curr Opin Colloid Interface Sci;2:531-537.
26. Said S., Mahrous H., Kassem A. (1976) Clinical study on the antifungal activity of griseofulvin in the presence of surfactants. Infection;4:49-50.
27. Bodor N., Venkatraghavan V., Winwood D., Estes K., Brewster M.E. (1989) Improved delivery through biological membranes xli. Brain-enhanced delivery of chlorambucil. Int J Pharm;53:195-208.
28. Yousef R.T., Ghobashy A.A. (1968) Solubilization of chloramphenicol by benzalkonium chloride and study of their combined activity against pseudomonas aeruginosa. Acta Pharm Suec;5:385-392.
29. Pop E. (1994) Targeting penicillins to the central nervous system: chemical delivery and redox analogs. Adv Drug Delivery Rev;14:211-226.
30. Krande P., Mitragotri S. (2002) High throughput screening of transdermal formulations. Pharm Res;19:655-660.
31. Müllertz A., Ogbonna A., Ren S., Rades T. (2010) New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J Pharm Pharmacol;62:1622-1636.
32. Cottarel G., Wierzbowki J. (2007) Combination drugs, an emerging option for antibacterial therapy. Trends Biotechnol;25:547-555.
33. NCCLS (2003) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 6th edn. In M2-A6. Wayne, PA, USA: National Committee on Clinical Laboratory Standards.
34. Davidson A.G., Stenlake J.B. (1974) The spectrophotometric determination of ampicillin and cloxacillin in combined injections. Analyst;99:476-481.
35. Samanta A. (2006) Dynamic stokes shift and excitation wavelength dependent fluorescence of dipolar molecules in room temperature ionic liquids. J Phys Chem B;110:13704-13716.
36. Paul A., Samanta A. (2006) Optical absorption and fluorescence studies on imidazolium ionic liquids comprising the bis(trifluoromethanesulphonyl)imide anion. J Chem Sci;118:335-340.
37. Mandal P.K., Paul A., Samanta A. (2006) Excitation wavelength dependent fluorescence behavior of the room temperature ionic liquids and dissolved dipolar solutes. J Photochem Photobiol A: Chem;182:113-120.
38. NCCLS (2006) Performance Standards for Antimicrobial Disk Susceptibility Tests, 8th edn. Approved standard. In M2-A8. Villanova, PA: National Committee on Clinical Laboratory Standards.
39. Stevens M.G., Olsen S.C. (1993) Comparative analysis of using MTT and xtt in colorimetric assays for quantitating bovine neutrophil bactericidal activity. J Immunol Meth;157:225-231.
40. Stowe R.P., Koenig D.W., Mishra S.K., Pierson D.L. (1995) Nondestructive and continuous spectrophotometric measurement of cell respiration using a tetrazolium-formazan microemulsion. J Microbiol Meth;22:283-292.
41. Ioannou C.J., Hanlon G.W., Denyer S.P. (2007) Action of disinfectant quaternary ammonium compounds against Staphylococcus aureus. Antimicrob Agents Chemother;51:296-306.
42. Ahlstrom B., Thompson R.A., Edebo L. (1999) The effect of hydrocarbon chain length, ph, and temperature on the binding and bactericidal effect of amphiphilic betaine esters on Salmonella typhimurium. APMIS;107:318-324.
43. Luis P., Ortiz I., Aldaco R., Irabien A. (2007) A novel group contribution method in the development of a qsar for predicting the toxicity (Vibrio fischeri ec50) of ionic liquids. Ecotoxicol Environ Saf;67:423-429.
44. Ranke J., Molter K., Stock F., Bottin-Weber U., Poczobutt J., Hoffmann J., Ondruschka B. (2004) Biological effects of imidazolium ionic liquids with varying chain lengths in acute Vibrio fischeri and wst-1 cell viability assays. Ecotoxicol Environ Saf;58:396-404.
45. Couling D.J., Bernot R.J., Docherty K.M., Dixon J.K., Maginn E.J. (2006) Assessing the factors responsible for ionic liquid toxicity to aquatic organisms via quantitative structure-property relationship modelling. Green Chem;8:82-90.
46. Scholar E.M., Pratt W.B. (2000) The Antimicrobial Drugs. New York: Oxford.
47. Maloy S.R., Cronan J.E., Freifelder D. (1994) Microbial Genetics. Sudbury: Jones and Bartlett Publishers.
48. Brooks G.F., Butel J.S., Morse S.A., Brooks G., Butel J., Morse S. (2004) Jawetz, Melnick, & Adelberg's Medical Microbiology (LANGE Basic Science). McGraw-Hill Medical; 23 Ed. New York, NY: McGraw-Hill.
49. Tipper D.J., Strominger J.L. (1965) Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-d-alanyl-d-alanine. Proc Natl Acad Sci USA;54:1133-1141.
50. Krysinkski J. (1995) Application of the rough sets theory to the analysis of structure-activity-relationships of antimicrobial pyridinium compounds. Pharmazie;50:593-597.
51. Pernak J., Sobaszkiewicz K., Mirska I. (2003) Anti-microbial activities of ionic liquids. Green Chem;5:52-56.
52. Suling W.J., O'Leary W.M. (1975) Effect of surfactants on antibiotic resistance. Antimicrob Agents Chemother;8:334-343.